Overdiagnosis, Sojourn Time, and Sensitivity in the Copenhagen Mammography Screening Program
- 1 July 2006
- journal article
- Published by Hindawi Limited in The Breast Journal
- Vol. 12 (4) , 338-342
- https://doi.org/10.1111/j.1075-122x.2006.00272.x
Abstract
The goal of this research was to estimate the overdiagnosis at the first and second screens of the mammography screening program in Copenhagen, Denmark. This study involves a mammography service screening program in Copenhagen, Denmark, with 35,123 women screened at least once. We fit multistate models to the screening data, including preclinical incidence of progressive cancers and nonprogressive (i.e., overdiagnosed) cancers. We estimated mean sojourn time as 2.7 years (95% confidence interval [CI] 2.2-3.1) and screening test sensitivity as 100% (95% CI 99.8-100). Overdiagnosis was estimated to be 7.8% (95% CI 0.3-26.5) at the first screen and 0.5% (95% CI 0.02-2.1) at the second screen. This corresponds to 4.8% of all cancers diagnosed among participants during the first two invitation rounds and following intervals. A modest overdiagnosis was estimated for the Copenhagen screening program, deriving almost exclusively from the first screen. The CIs were very broad, however, and estimates from larger datasets are warranted.Keywords
This publication has 10 references indexed in Scilit:
- Breast cancer incidence after the introduction of mammography screeningCancer, 2006
- The influence of mammographic screening on national trends in breast cancer incidenceEuropean Journal Of Cancer Prevention, 2005
- Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort studyBMJ, 2005
- Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programmeJournal of Medical Screening, 2004
- Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?Journal of Medical Screening, 2004
- Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screeningEuropean Journal Of Cancer, 2003
- The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the diseaseEuropean Journal Of Cancer, 2003
- A Markov Chain Method to Estimate the Tumour Progression Rate from Preclinical to Clinical Phase, Sensitivity and Positive Predictive Value for Mammography in Breast Cancer ScreeningJournal of the Royal Statistical Society: Series D (The Statistician), 1996
- Regional trends in breast cancer incidence and mortality in Denmark prior to mammographic screeningBritish Journal of Cancer, 1994
- Modelling the Analysis of Breast Cancer Screening Programmes: Sensitivity, Lead Time and Predictive Value in the Florence District Programme (1975–1986)International Journal of Epidemiology, 1991